China Continuous Glucose Monitoring Devices Market Size Is Projected to Reach USD 405.5 Million at a CAGR Of 22.8% by 2028 | Rising incidence of diabetes

High prevalence of diabetes is driving growth of the continuous glucose monitoring devices. According to the International Diabetes Federation in November 2019, around 463 million adults in the age group of 20 to 79 years are diagnosed with diabetes in 2019, and it is estimated that the total diabetes population will reach nearly 700 million by 2045 globally.

LIMITED TIME OFFER – Hurry Up!!!
Buy Now To Avail Flat 30% Off

Buy This Complete Business Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/3675

Continuous glucose management device are advanced tool that helps in regulating and monitoring the glucose equilibrium of the body.

The China continuous glucose monitoring devices market size is estimated to be valued at US$ 78.2 Mn in 2019 and is expected to exhibit a CAGR of 22.8% over the forecast period (2019–2027).

Growing incidences of diabetes in China is projected to foster the market growth over the forecast period

According to the International Diabetes Federation’s 2019 report, around 116 million people in between the age group of 20-79 years are suffering from diabetes in China.

Moreover, advent of advanced glucose monitoring devices is projected to propel the market growth during forecast period. For instance, in September 2019, Abbott Laboratories launched its upgraded FreeStyle Libre 14 day Glucose Monitoring device. The FreeStyle Libre 14 day system incorporates a wearable sensor that is placed on the back of the upper arm. The wearer can use their smartphone to get real-time information on glucose measurement simply by holding it near the sensor. An app on the phone will display current glucose levels, and information on how glucose levels are changing at that moment and trends in glucose levels over the previous eight hours and up to 90 days.

On the other hand, high cost of continuous glucose monitoring devices is projected to restrict market growth. Continuous glucose monitoring devices are more expensive than standard glucose meters as the sensor lifetime is a key factor affecting the cost, inconvenience and user acceptance. Also, unfavorable health plans, insurance companies for continuous glucose monitoring devices across most countries has led to certain reluctance among patients towards the adoption of these devices which cost around US$ 3,000 per year per patient.

Convenience offered by the continuous glucose monitoring devices (CGM) over self-monitoring devices is projected to augment the market growth over the forecast period

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/3675

The introduction of continuous glucose monitoring devices marked a remarkable change in diabetes health care. These advanced device provide real-time information on blood glucose levels less invasively than conventional glucose monitoring devices. Continuous glucose monitoring devices automatically and constantly track blood glucose levels entire the day, thus providing information that can be analyzed to make informed decisions about managing dietary habits, physical activity, and medication. CGM systems require fewer finger sticks and allows sharing and transfer of data for further analysis.

Moreover, growing launches of CGM devices is projected to drive the growth of the China continuous glucose monitoring devices market. For instance in January 2019, Ascensia Diabetes Care, a Switzerland-based technology company formed through the merger of Bayer Health’s diabetes division and Panasonic Healthcare, is officially moving into the CGM space through a partnership with Huzhou, China-based Zhejiang POCTech. With this partnership Ascensia launched the branded version of POCTech’s CE-Marked CGM devices in several markets including China. Currently Ascensia, is focused on development of CGM devices for in-house application and company will co-develop a next generation product with POCTech.

Key Players

Major players operating in the China continuous glucose monitoring devices market include Medtronic PLC, Abbott Laboratories, Medtrum Technologies, Inc., Senseonics, Nemaura, STMicroelectronics, NXP Semiconductors, Qualcomm, Taiwan Semiconductor Manufacturing Company Limited, GE Healthcare, Microchip Technology Inc., Texas Instruments Inc., Micron Technology Inc., Renesas Electronics Corporation, and Toshiba Corporation.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/3675

Reasons to Purchase This Report

• Current and future of China Continuous Glucose Monitoring Devices Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Component
     • Market Snippet, By End User
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Developments
   • Regulatory Scenario
   • Reimbursement Scenario
   • Recent Product Launch
   • PEST Analysis
   • Epidemiology
4. China Continuous Glucose Monitoring Devices Market, By Component, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Transmitters
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Receivers
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Insulin Pumps
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Sensors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
5. China Continuous Glucose Monitoring Devices Market, By End User, 2016 – 2027, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2019 and 2027 (%)
     • Y-o-Y Growth Analysis, 2017 – 2027
     • Segment Trends
   • Hospitals & Clinics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Homecare settings
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)

View Press Release: https://www.coherentmarketinsights.com/press-release/china-continuous-glucose-monitoring-devices-market-2968